![Michael Messinger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Messinger
Finansdirektör/CFO på
SEASTAR MEDICAL HOLDING CORPORATION
Förmögenhet: 6 423 $ per 2026-06-30
Profil
Michael Messinger is Director at Filament Health Corp.
since 2024.
Mr. Messinger is Chief Financial Officer at Seastar Medical Holding Corp.
starting in 2025.
Formerly, Mr. Messinger was Finance Director at Lexicon Pharmaceuticals, Inc. from 2001 to 2012.
Mr. Messinger worked as Auditor at Ernst & Young LLP from 1996 to 1999.
Mr. Messinger served as Controller at Coelacanth Corp.
from 1999 to 2001.
Mr. Messinger was President, Chief Executive & Operating Officer at ContraFect Corp.
in 2023.
Mr. Messinger completed undergraduate education at the University of Michigan.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-31 | 1 750 ( 0,04 % ) | 6 423 $ | 2026-06-30 |
Aktiva positioner av Michael Messinger
| Företag | Position | Start |
|---|---|---|
| FILAMENT HEALTH CORP. | Direktör/Styrelseledamot | 2024-03-28 |
| SEASTAR MEDICAL HOLDING CORPORATION | Finansdirektör/CFO | 2025-11-14 |
Tidigare kända positioner av Michael Messinger
| Företag | Position | Slut |
|---|---|---|
| CONTRAFECT CORPORATION | Verkställande Direktör | 2023-12-04 |
| LEXICON PHARMACEUTICALS, INC. | Finansdirektör/CFO | 2012-01-01 |
Coelacanth Corp.
 Coelacanth Corp. Miscellaneous Commercial ServicesCommercial Services Researches drug development | Comptroller/Controller/Revisor | 2001-01-01 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Comptroller/Controller/Revisor | 1999-01-01 |
Michael Messingers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
65
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Lexicon Pharmaceuticals, Inc.
 Lexicon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Coelacanth Corp.
Coelacanth Corp. Miscellaneous Commercial ServicesCommercial Services Researches drug development | Commercial Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ContraFect Corp.
 ContraFect Corp. BiotechnologyHealth Technology Engages in discovery and development of direct lytic agents for life-threatening & drug-resistant infectious diseases | Health Technology |
Filament Health Corp.
 Filament Health Corp. Pharmaceuticals: OtherHealth Technology Develops psychedelic pharmaceuticals | Health Technology |
Seastar Medical Holding Corp.
 Seastar Medical Holding Corp. Medical SpecialtiesHealth Technology Manufactures medical devices and develops technology solutions | Health Technology |
